GTP Bioways

Exciting news! 🚀 We’re heading to the Festival of Biologics in Basel! It’s your chance to dive into groundbreaking solutions, meet brilliant minds, and uncover fresh opportunities for collaboration. Let’s chat, connect, and spark some innovation together! 💡 Who's in? 🙌 See you there! #FOB2024 #Biologics #Innovation #Networking

We’re thrilled to be at The World Vaccine Congress #WVCEU in Barcelona from October 28-31, where GTP Bioways, Olon and Lovaltech will be taking the stage together! Join us for our presentation: 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗖𝗠𝗖 𝗣𝗮𝘁𝗵𝘄𝗮𝘆: 𝗟𝗼𝘃𝗮𝗹𝘁𝗲𝗰𝗵’𝘀 𝗝𝗼𝘂𝗿𝗻𝗲𝘆 𝗳𝗿𝗼𝗺 𝗟𝗮𝗯 𝗕𝗲𝗻𝗰𝗵 𝘁𝗼 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹-𝗚𝗿𝗮𝗱𝗲 𝗡𝗮𝘀𝗮𝗹 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 Lovaltech, a pioneering French start-up, partnered with GTP Bioways in 2022 to tackle the complexities of CMC development and bring their protein-based nasal vaccine to life. From cell bank creation to clinical trials, we’ll be diving into how we’ve successfully collaborated to produce the first clinical batches of this innovative vaccine in 2024. 🚀 Here’s what we’ll cover: ◾ Process development ◾ Analytical method optimization ◾ Scale-up & viral risk management ◾ The transition from academic research to GMP compliance 🎤 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: Gaëtane Rouvray, CMC director from Lovaltech will be presenting during the 𝗕𝗶𝗼𝗽𝗿𝗼𝗰𝗲𝘀𝘀 & 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 on the 30th October.  Following the presentation, Yann Desfougères, Project Design Manager at GTP Bioways, will be ready to answer your questions, alongside with Gaëtane, during the Q&A session. 💬 𝗟𝗲𝘁’𝘀 𝗖𝗼𝗻𝗻𝗲𝗰𝘁! Don’t miss the chance to speak with Nancy Martinez and Yann Desfougères from GTP Bioways, along with Amaia Mendivil from Olon, at booth #74. They’ll be available throughout the event to discuss exciting breakthroughs, explore potential partnerships, and share more about our innovative journey. This is your opportunity to hear firsthand about the critical milestones we’ve achieved and the innovations that are shaping the future of vaccine development! #WorldVaccineCongress #VaccineDevelopment #Biotechnology #ClinicalTrials #Innovation #CMCPathway

Fresh, dynamic, and now fully integrated into Olon’s global family, this isn’t just a visual change—it’s a reflection of our continued evolution. What does this mean for you? As a one-stop 𝗖𝗗𝗠𝗢 𝗳𝗼𝗿 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝗮𝗻𝗱 𝗯𝗶𝗼𝗰𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗲𝘀, we’re committed to providing CMC leaders in biotech with seamless, comprehensive support. From 𝗲𝗮𝗿𝗹𝘆 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝘁𝗼 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻, we’re here to accelerate your clinical-stage candidates every step of the way. Our mission remains the same: 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝘆𝗼𝘂 𝘁𝗼 𝗯𝗿𝗶𝗻𝗴 𝗹𝗶𝗳𝗲-𝘀𝗮𝘃𝗶𝗻𝗴 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘁𝗼 𝗰𝗹𝗶𝗻𝗶𝗰𝘀 𝗮𝗻𝗱 𝗺𝗮𝗿𝗸𝗲𝘁𝘀 𝘄𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲. Let’s advance together. #CDMO #Biotech #Biotherapeutics

En tant que partenaire du projet Bio'Occ, notre reconnaissance va à GTP Bioways. Cette entreprise est spécialisée dans le domaine des biotechnologies. Forte de son expertise en bioproduction et en développement de biothérapies, elle joue un rôle crucial dans la promotion de l'innovation et de l'excellence scientifique en région Occitanie. Avec son engagement en faveur du développement durable et de l'efficacité des processus biologiques, l’entreprise GTP Bioways contribue activement à l'écosystème biotechnologique régional, en favorisant la croissance économique et en répondant aux défis de santé publique grâce à des solutions novatrices. Notre objectif : attirer et former les talents de demain ! #BioOcc #Biothérapie #Bioproduction #ThérapieGénique #ThérapieCellulaire #Innovation //// As a partner in the Bio'Occ project, our thanks go to GTP Bioways. This company specialises in biotechnology. With its expertise in bioproduction and the development of biotherapies, it plays a crucial role in promoting innovation and scientific excellence in Occitania. With its commitment to sustainable development and the efficiency of biological processes, GTP Bioways actively contributes to the regional biotechnology ecosystem, promoting economic growth and responding to public health challenges with innovative solutions. Our aim: to attract and train the talent of tomorrow! #BioOcc #Biotherapy #Bioproduction #GeneTherapy #CellTherapy #Innovation

📅 𝗙𝗲𝘀𝘁𝗶𝘃𝗮𝗹 𝗼𝗳 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝟮𝟬𝟮𝟯 - 𝗕𝗮𝘀𝗲𝗹 📅 We are excited to share that GTP Bioways will be attending this year’s Festival of Biologics #FOB2024 in Basel, a key event for the global biologics community. Amira MASTOURI, PhD will be on-site, ready to discuss everything from process development to GMP manufacturing, and of course, explore new opportunities for collaboration. Attending too? Let’s meet up, talk shop, and maybe even discuss how we can change the world (or at least your pipeline). 🚀 👉 Drop a comment below or slide into Amira’s DMs. See you there! 👋

🔬 𝗠𝗮𝘀𝘁𝗲𝗿𝗶𝗻𝗴 𝗖𝗼𝗺𝗽𝗹𝗲𝘅 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗣𝘂𝗿𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻: 𝗔 𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆 𝗼𝗻 𝗔𝗰𝗵𝗶𝗲𝘃𝗶𝗻𝗴 𝗢𝗽𝘁𝗶𝗺𝗮𝗹 𝗗𝗼𝘄𝗻𝘀𝘁𝗿𝗲𝗮𝗺 𝗣𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴 At GTP Bioways, we took on one of the toughest challenges in protein purification—producing a recombinant protein with a molecular weight over 200 kDa and a pI around 9. This wasn’t just any project. It required rigorous DSP innovation to meet purity standards. How did we do it? ◼ 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲𝗱 𝘄𝗮𝘀𝗵𝗶𝗻𝗴 𝗰𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻𝘀 to minimize host cell proteins. ◼ 𝗥𝗲𝗳𝗶𝗻𝗲𝗱 𝗹𝗼𝗮𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗲𝗹𝘂𝘁𝗶𝗼𝗻 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 to separate the target protein effectively. ◼ 𝗦𝗰𝗿𝗲𝗲𝗻𝗲𝗱 𝗮𝗹𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝘃𝗲 𝗽𝗼𝗹𝗶𝘀𝗵𝗶𝗻𝗴 𝗺𝗲𝗱𝗶𝗮 to ensure the highest purity. This case study is a must-read for anyone in the field. Curious about the full process? Dive in now 𝘞𝘩𝘢𝘵’𝘴 𝘺𝘰𝘶𝘳 𝘣𝘪𝘨𝘨𝘦𝘴𝘵 𝘤𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦 𝘪𝘯 𝘱𝘳𝘰𝘵𝘦𝘪𝘯 𝘱𝘶𝘳𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯? Let’s connect and discuss!

🔬 𝗠𝗮𝘀𝘁𝗲𝗿𝗶𝗻𝗴 𝗖𝗼𝗺𝗽𝗹𝗲𝘅 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗣𝘂𝗿𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻: 𝗔 𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆 𝗼𝗻 𝗔𝗰𝗵𝗶𝗲𝘃𝗶𝗻𝗴 𝗢𝗽𝘁𝗶𝗺𝗮𝗹 𝗗𝗼𝘄𝗻𝘀𝘁𝗿𝗲𝗮𝗺 𝗣𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴 At GTP Bioways, we recently tackled one of the most challenging projects in protein purification—producing a recombinant protein with a high molecular weight (> 200 kDa) and a pI around 9. This task demanded a rigorous and innovative approach to downstream processing (DSP). This case study is a blueprint for anyone facing similar challenges in protein purification. We will dive into: ◼ 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗶𝗻𝗴 𝗪𝗮𝘀𝗵𝗶𝗻𝗴 𝗖𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻𝘀 ◼ 𝗥𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗟𝗼𝗮𝗱𝗶𝗻𝗴 𝗖𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻𝘀 ◼ 𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗘𝗹𝘂𝘁𝗶𝗼𝗻 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 ◼ 𝗦𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗔𝗹𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝘃𝗲 𝗣𝗼𝗹𝗶𝘀𝗵𝗶𝗻𝗴 𝗠𝗲𝗱𝗶𝗮 Flexibility and innovation in DSP are crucial to overcoming the complexities of high molecular weight proteins. Curious about the details? Dive into the full case study now > https://lnkd.in/d3HDwBdy 𝘞𝘩𝘢𝘵’𝘴 𝘺𝘰𝘶𝘳 𝘣𝘪𝘨𝘨𝘦𝘴𝘵 𝘤𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦 𝘪𝘯 𝘱𝘳𝘰𝘵𝘦𝘪𝘯 𝘱𝘶𝘳𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯? Let’s discuss!

🔬 𝗠𝗮𝘀𝘁𝗲𝗿𝗶𝗻𝗴 𝗖𝗼𝗺𝗽𝗹𝗲𝘅 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗣𝘂𝗿𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻: 𝗔 𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆 𝗼𝗻 𝗔𝗰𝗵𝗶𝗲𝘃𝗶𝗻𝗴 𝗢𝗽𝘁𝗶𝗺𝗮𝗹 𝗗𝗼𝘄𝗻𝘀𝘁𝗿𝗲𝗮𝗺 𝗣𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴 Imagine working with a recombinant protein with a molecular weight exceeding 200 kDa and a pI around 9. 🧬 At GTP Bioways, we recently took on this complex challenge, requiring a meticulous approach to downstream processing (DSP). Curious about how we achieved it? Stay tuned for the full story. #Biotech #ProteinPurification #CaseStudy #Innovation

At GTP Bioways, we understand that every #bioconjugate project is unique. That’s why our services are tailored to meet your specific needs. Here’s how we stand out: 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗔𝗰𝗿𝗼𝘀𝘀 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 > We excel in both mammalian and microbial expression systems, managing a wide range of bioconjugates. 𝗢𝘃𝗲𝗿 𝗮 𝗗𝗲𝗰𝗮𝗱𝗲 𝗼𝗳 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 > With more than ten years in perfecting conjugation processes, we handle various biomolecules and cytotoxic payloads with precision. 𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗖𝗠𝗖 𝗦𝘂𝗽𝗽𝗼𝗿𝘁 > We guide you through your entire CMC journey, ensuring success at every step. But that’s not all! With our recent acquisition by Olon, we now offer a 𝘁𝗿𝘂𝗹𝘆 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗔𝗗𝗖 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻. From mAbs, linkers, and cytotoxic payloads to final conjugation—we manage it all under one roof. Ready to boost your bioconjugate clinical development? Let’s talk or connect directly with Fanny GOY!

📅 𝗕𝗶𝗼𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗶𝗻 𝗧𝗼𝘂𝗿𝘀, 𝗙𝗿𝗮𝗻𝗰𝗲 📅 We are thrilled to announce our participation in the upcoming Bioproduction Congress #BIOPC2024, hosted by MabDesign. This is your chance to connect with industry leaders and gain valuable insights that could transform your bioproduction strategies. Our experts, Yann Desfougères and Matthieu CULIE, will share their insights on how “manufacturability drives product developability.” They’ll draw from our recent projects to provide valuable takeaways on bioprocess development and GMP production—insights you won’t want to miss! We’re also excited to announce that our CEO, Alain Sainsot, will participate in a roundtable on “𝗛𝗼𝘄 𝘁𝗼 𝗦𝗲𝗹𝗲𝗰𝘁 𝗬𝗼𝘂𝗿 𝗖𝗗𝗠𝗢? 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗙𝗿𝗮𝗻𝗰𝗲 𝗕𝗶𝗼𝘁𝗲𝗰𝗵’𝘀 𝗕𝗶𝗼𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗲”. He’ll be joined by industry leaders Frédéric Desdouits, CEO of TreeFrog Therapeutics, and Pierre-Noël Lirsac, CEO of CELLforCURE by Seqens. This is a fantastic opportunity to gain expert perspectives on optimizing your future collaborations! Fanny GOY will be there, eager to discuss your bioproduction needs and tackle any CMC-related challenges. If you’re attending the congress, let’s team up and explore how we can overcome challenges together! While we may not have stunning views of the Loire Valley from the congress center, we promise engaging conversations that could lead to amazing collaborations! Are you going to the Bioproduction Congress? We’d love to meet you! 👉 Drop a comment below or send a DM to schedule a meeting with our team. Looking forward to seeing you in Tours!